Physician profile
Benjamin A Barrett
NPI 1922607373
$2,286.12
in general payments reported to CMS, 2019-2025
28 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2023: $366 · 2024: $423 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.14 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $428.44 | 2025 | Korlym |
| Pfizer INC. | $212.86 | 2023-2025 | |
| Glaxosmithkline, LLC. | $207.27 | 2023-2025 | Arexvy, Trelegy Ellipta, Bexsero |
| Bayer Healthcare Pharmaceuticals INC. | $201.80 | 2023-2025 | |
| Novo Nordisk INC | $176.21 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $137.61 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Amgen INC. | $114.24 | 2023-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $101.87 | 2023-2025 | Airsupra, Breztri |
| Medical Device Business Services, INC. | $100.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $57.92 | 2024-2025 | Voquezna |
| Stryker Corporation | $57.09 | 2021 | |
| Insulet Corporation | $55.73 | 2025 | Omnipod |
| Exact Sciences Corporation | $48.37 | 2023-2025 | Cologuard Collection Kit |
| Abbvie INC. | $47.33 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.73 | 2023-2025 | Jardiance, Glyxambi, Tradjenta |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $37.02 | 2023-2025 | Lybalvi |
| Medtronic, INC. | $32.50 | 2024 | Intellis Adaptivestim |
| Merck Sharp & Dohme LLC | $28.02 | 2025 | Capvaxive, Gardasil 9, Vaxelis |
| Vertex Pharmaceuticals Incorporated | $24.25 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $23.92 | 2023 | Rexulti |
| Seqirus USA INC | $21.76 | 2025 | Fluad, Flucelvax |
| Inspire Medical Systems, INC. | $21.69 | 2025 | Inspire |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.17 | 2025 | Caplyta |
| Sanofi Pasteur INC. | $19.50 | 2023 | |
| Astellas Pharma US INC | $18.18 | 2023 | Myrbetriq |
| Hologic Sales and Service, LLC | $17.42 | 2023 | Thinprep 2000 Processor, Aptima |
| Irhythm Technologies, INC. | $16.69 | 2024 | Zio Monitor, Zio Xt Patch |
| Azurity Pharmaceuticals, INC. | $16.53 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.